Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cellebrite DI's share price for the quarter that ended in Mar. 2026 was $13.78. Cellebrite DI's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 249.4 Mil. Therefore, Cellebrite DI's market cap for the quarter that ended in Mar. 2026 was $3,437.3 Mil.
Cellebrite DI's quarterly market cap
declined
from Sep. 2025 ($4,530.0 Mil) to Dec. 2025 ($4,481.9 Mil) and
declined
from Dec. 2025 ($4,481.9 Mil) to Mar. 2026 ($3,437.3 Mil).
Cellebrite DI's annual market cap
increased
from Dec. 2023 ($1,760.0 Mil) to Dec. 2024 ($5,166.6 Mil) but then
declined
from Dec. 2024 ($5,166.6 Mil) to Dec. 2025 ($4,481.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cellebrite DI's Enterprise Value for Today is $3,397.7 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cellebrite DI Market Cap Related Terms
Cellebrite DI Market Cap Historical Data
* Premium members only.
The historical data trend for Cellebrite DI's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Software - Infrastructure subindustry, Cellebrite DI's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellebrite DI Market Cap vs Software Industry
For the Software industry and Technology sector, Cellebrite DI's Market Cap distribution charts can be found below:
* The bar in red indicates where Cellebrite DI's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cellebrite DI's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellebrite DI (CLBT) has a Market Cap of $3,804.0 Mil as of Aug. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cellebrite DI and its competitors. According to the industry distribution chart, Cellebrite DI ranks #223 out of 2934 companies in the Software industry, placing it in the top 7.6%.
Is Cellebrite DI's Market Cap too high?
Cellebrite DI's current Market Cap is $3,804.0 Mil. The Software industry median Market Cap is 67.67. Cellebrite DI's value of $3,804.0 Mil is 5521.4% above this industry median. Based on the distribution chart, Cellebrite DI ranks #223 out of 2934 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Cellebrite DI has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's Market Cap compare to TENB and PAY?
According to the Software industry distribution chart, Cellebrite DI ranks #223 out of 2934 companies for Market Cap. This places Cellebrite DI in the top 8% of its industry — outperforming the majority of peers. The industry median Market Cap is 67.67. Cellebrite DI's value of $3,804.0 Mil is 5521.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Software company?
The median Market Cap among Software companies is 67.67, based on 2,934 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cellebrite DI's current Market Cap of $3,804.0 Mil is 5521.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cellebrite DI and its competitors. For the Software industry, the median Market Cap is 67.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellebrite DI's current Market Cap is $3,804.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (CLBT) is currently considered Fairly Valued. The stock's GF Value™ is $16.08, compared to a current price of $15.25 — trading 5.2% below its estimated fair value. The current Market Cap is $3,804.0 Mil and 5521.4% above the Software industry median of 67.67. Cellebrite DI's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cellebrite DI (CLBT), the current Market Cap is $3,804.0 Mil as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cellebrite DI (CLBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued.
The current stock price of $15.25 is trading 5.2% below its estimated GF Value™ of $16.08.
GuruFocus considers Cellebrite DI to be Fairly Valued.
Key valuation signals for CLBT:
Market Cap: $3,804.0 Mil
GF Value™: $16.08 vs. price of $15.25 (5.2% below fair value)
Industry Position: 5521.4% above the Software median (#223 of 2934)
No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
82GF Score
Get the complete analysis for CLBT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLBT has been successfully added to your 
